Blue Belt ties up $2.4m in first equity round
This article was originally published in Clinica
"Smart" surgical instruments developer Blue Belt Technologies has completed a $2.4m series A financing round. The funds were provided by private investors, Pittsburgh Life Sciences Greenhouse and Innovation Works. The financing will enable Pittsburgh-based Blue Belt to finalise development and prepare its FDA submission for its core product, the precision freehand sculptor (PFS), a handheld tool for computer-assisted bone cutting. Spun out of Carnegie Mellon University, Blue Belt says the PFS is designed to be integrated into the estimated 8,000 navigation systems installed worldwide in a cost effective manner. The company is also developing an independent platform for other bone based procedures.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.